| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 GNAT2 OR11H2 OR2A2 | 1.31e-29 | 884 | 163 | 51 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR11H2 OR2A2 | 1.72e-28 | 431 | 163 | 38 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR51A2 OR5D16 OR2A14 IL12RB2 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R TMEM63C OR1F2P OR2W5P OR1C1 HTR3C OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 GNAT2 GRIN3B OR11H2 OR2A2 | 1.66e-24 | 1353 | 163 | 55 | GO:0004888 |
| GeneOntologyMolecularFunction | Gq/11-coupled serotonin receptor activity | 5.34e-07 | 3 | 163 | 3 | GO:0001587 | |
| GeneOntologyMolecularFunction | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding | 6.62e-05 | 2 | 163 | 2 | GO:0071886 | |
| GeneOntologyMolecularFunction | serotonin binding | 1.44e-04 | 13 | 163 | 3 | GO:0051378 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.98e-04 | 3 | 163 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphoserine O-acyltransferase activity | 3.93e-04 | 4 | 163 | 2 | GO:0106263 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphoethanolamine O-acyltransferase activity | 3.93e-04 | 4 | 163 | 2 | GO:0106262 | |
| GeneOntologyMolecularFunction | odorant binding | 6.18e-04 | 127 | 163 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | amine binding | 6.37e-04 | 21 | 163 | 3 | GO:0043176 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 6.52e-04 | 5 | 163 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 7.34e-04 | 22 | 163 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 1.08e-03 | 25 | 163 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 1.21e-03 | 26 | 163 | 3 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 1.21e-03 | 26 | 163 | 3 | GO:0004950 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.38e-03 | 100 | 163 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 1.51e-03 | 28 | 163 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.52e-03 | 151 | 163 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | 1-acylglycerophosphocholine O-acyltransferase activity | 1.80e-03 | 8 | 163 | 2 | GO:0047184 | |
| GeneOntologyMolecularFunction | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 1.80e-03 | 8 | 163 | 2 | GO:0004169 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.03e-03 | 31 | 163 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.08e-03 | 343 | 163 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | 2-acylglycerol-3-phosphate O-acyltransferase activity | 2.30e-03 | 9 | 163 | 2 | GO:0047144 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 8.86e-32 | 485 | 163 | 42 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 ADCY3 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 8.45e-31 | 547 | 163 | 43 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 2.09e-30 | 524 | 163 | 42 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 HTR2A OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 1.10e-29 | 582 | 163 | 43 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR11H2 OR2A2 | 5.92e-29 | 432 | 163 | 38 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 ADCY3 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR11H2 OR2A2 | 6.12e-29 | 465 | 163 | 39 | GO:0007608 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 ADCY3 ADCY5 OR1J2 OR4M2B ITPR1 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 CCR3 NR3C2 OR4X2 GNAT1 GNAT2 OR11H2 HTT OR2A2 | 3.50e-27 | 1395 | 163 | 58 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 HTR2A OR6S1 OR4C11 OR6K2 PIEZO1 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 6.56e-27 | 722 | 163 | 44 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 HTR2A OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR52P1 LRIT3 ADCY3 OR1J2 OR4M2B OR1D2 OR51F1 OR51G2 SPTBN4 OR52B4 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 TMEM150C GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 GNAT2 OR11H2 OR2A2 | 1.14e-22 | 1072 | 163 | 47 | GO:0007600 |
| GeneOntologyBiologicalProcess | phospholipase C-activating serotonin receptor signaling pathway | 4.85e-07 | 3 | 163 | 3 | GO:0007208 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylinositol biosynthetic process | 4.85e-07 | 3 | 163 | 3 | GO:0010513 | |
| GeneOntologyBiologicalProcess | serotonin receptor signaling pathway | 1.19e-06 | 11 | 163 | 4 | GO:0007210 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol biosynthetic process | 4.79e-06 | 5 | 163 | 3 | GO:0010511 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 8.61e-06 | 61 | 163 | 6 | GO:0007187 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 1.14e-05 | 64 | 163 | 6 | GO:1903351 | |
| GeneOntologyBiologicalProcess | response to dopamine | 1.36e-05 | 66 | 163 | 6 | GO:1903350 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 1.62e-05 | 68 | 163 | 6 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 1.62e-05 | 68 | 163 | 6 | GO:0071870 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 2.14e-05 | 146 | 163 | 8 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 2.25e-05 | 147 | 163 | 8 | GO:0051283 | |
| GeneOntologyBiologicalProcess | response to catecholamine | 2.44e-05 | 73 | 163 | 6 | GO:0071869 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 2.48e-05 | 149 | 163 | 8 | GO:0051282 | |
| GeneOntologyBiologicalProcess | response to monoamine | 2.64e-05 | 74 | 163 | 6 | GO:0071867 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 3.00e-05 | 153 | 163 | 8 | GO:0051208 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 4.20e-05 | 259 | 163 | 10 | GO:0051651 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | HTR2A HTR2B SRD5A3 HTR2C MBOAT1 PIGG EFR3A PIKFYVE SLC44A1 LPCAT3 | 5.59e-05 | 268 | 163 | 10 | GO:0008654 |
| GeneOntologyBiologicalProcess | background adaptation | 6.21e-05 | 2 | 163 | 2 | GO:0120302 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPM4 CXCR3 HTR2A HTR2B HTR2C SLC24A3 ITPR1 ITPR2 TGFB2 GRIN3B ATP2A2 HTT | 6.92e-05 | 392 | 163 | 12 | GO:0070588 |
| GeneOntologyBiologicalProcess | maintenance of location | CXCR3 HTR2A HTR2B HTR2C VPS13C FFAR2 BDH2 ITPR1 ITPR2 TGFB2 SOAT2 HTT | 7.63e-05 | 396 | 163 | 12 | GO:0051235 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 9.14e-05 | 133 | 163 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid biosynthetic process | 1.01e-04 | 12 | 163 | 3 | GO:0071073 | |
| GeneOntologyBiologicalProcess | membrane depolarization during Purkinje myocyte cell action potential | 1.85e-04 | 3 | 163 | 2 | GO:0086047 | |
| GeneOntologyBiologicalProcess | membrane depolarization during bundle of His cell action potential | 1.85e-04 | 3 | 163 | 2 | GO:0086048 | |
| GeneOntologyBiologicalProcess | neural tissue regeneration | 1.85e-04 | 3 | 163 | 2 | GO:0097719 | |
| GeneOntologyBiologicalProcess | chemotaxis | TRPM4 CXCR3 GPR18 FFAR2 PLEKHG5 OR1D2 TGFB2 PIKFYVE PDGFD CCR3 CMTM7 PLP2 SERPIND1 | 2.45e-04 | 517 | 163 | 13 | GO:0006935 |
| GeneOntologyBiologicalProcess | positive regulation of phospholipid metabolic process | 2.52e-04 | 16 | 163 | 3 | GO:1903727 | |
| GeneOntologyBiologicalProcess | taxis | TRPM4 CXCR3 GPR18 FFAR2 PLEKHG5 OR1D2 TGFB2 PIKFYVE PDGFD CCR3 CMTM7 PLP2 SERPIND1 | 2.54e-04 | 519 | 163 | 13 | GO:0042330 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.74e-04 | 266 | 163 | 9 | GO:0019722 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | CXCR3 HTR2A HTR2B HTR2C SLC24A3 TRIM24 ITPR1 ITPR2 TGFB2 ATP2A2 HTT | 2.77e-04 | 389 | 163 | 11 | GO:0055074 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | TRPM4 HTR2A HTR2B HTR2C RB1 SESN3 HTR3C CPS1 ADCY5 KLHL22 ITPR1 ITPR2 NR3C2 PRKDC GRIN3B HTT | 3.16e-04 | 752 | 163 | 16 | GO:1901699 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | TRPM4 HTR2A HTR2B HTR2C HTR3C CPS1 TRIM24 ADCY3 ADCY5 ITPR1 ITPR2 SCGB2A1 NR3C2 HTT | 3.29e-04 | 605 | 163 | 14 | GO:0071407 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.40e-04 | 217 | 163 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 3.40e-04 | 217 | 163 | 8 | GO:0046474 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | TRPM4 CXCR3 HTR2A HTR2B HTR2C ABCA12 FFAR2 BDH2 SESN3 HKDC1 SLC24A3 CPS1 TRIM24 ADCY5 ITPR1 ITPR2 TGFB2 OR4M2 NR3C2 ATP2A2 SOAT2 HTT | 3.46e-04 | 1249 | 163 | 22 | GO:0048878 |
| GeneOntologyBiologicalProcess | Purkinje myocyte action potential | 3.69e-04 | 4 | 163 | 2 | GO:0086017 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 3.99e-04 | 44 | 163 | 4 | GO:0001580 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TRPM4 HTR2A HTR2B HTR2C UBE4B RB1 VPS13C SESN3 DUOX2 HTR3C CPS1 ECPAS TRIM24 ADCY5 KLHL22 ITPR1 ITPR2 NR3C2 PRKDC GRIN3B ATP2A2 HTT | 4.43e-04 | 1272 | 163 | 22 | GO:1901698 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 4.65e-04 | 286 | 163 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 5.58e-04 | 48 | 163 | 4 | GO:0050913 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid biosynthetic process | 5.80e-04 | 21 | 163 | 3 | GO:0071071 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | CXCR3 HTR2A HTR2B HTR2C SLC24A3 ITPR1 ITPR2 TGFB2 ATP2A2 HTT | 5.89e-04 | 359 | 163 | 10 | GO:0006874 |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 6.04e-04 | 49 | 163 | 4 | GO:0045823 | |
| GeneOntologyBiologicalProcess | sensitization | 6.11e-04 | 5 | 163 | 2 | GO:0046960 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | TRPM4 HTR2A HTR2B HTR2C DUOX2 HTR3C CPS1 TRIM24 ADCY3 ADCY5 ITPR1 ITPR2 TGFB2 SCGB2A1 SCN5A NR3C2 GNAT1 GNAT2 HTT | 6.36e-04 | 1048 | 163 | 19 | GO:0014070 |
| GeneOntologyBiologicalProcess | phosphatidylinositol biosynthetic process | 6.41e-04 | 132 | 163 | 6 | GO:0006661 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 6.52e-04 | 50 | 163 | 4 | GO:0050912 | |
| GeneOntologyBiologicalProcess | calcium ion transport | TRPM4 CXCR3 HTR2A HTR2B HTR2C SLC24A3 ITPR1 ITPR2 TGFB2 GRIN3B ATP2A2 HTT | 7.50e-04 | 509 | 163 | 12 | GO:0006816 |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 7.64e-04 | 23 | 163 | 3 | GO:0098664 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion mediated by integrin | 7.64e-04 | 23 | 163 | 3 | GO:0033630 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 8.14e-04 | 53 | 163 | 4 | GO:1903524 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell communication | 9.12e-04 | 6 | 163 | 2 | GO:0086068 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 9.12e-04 | 6 | 163 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte to ventricular cardiac muscle cell signaling | 9.12e-04 | 6 | 163 | 2 | GO:0086029 | |
| GeneOntologyBiologicalProcess | protein mannosylation | 9.81e-04 | 25 | 163 | 3 | GO:0035268 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | 1.03e-03 | 320 | 163 | 9 | GO:0006650 | |
| GeneOntologyBiologicalProcess | mannosylation | 1.10e-03 | 26 | 163 | 3 | GO:0097502 | |
| GeneOntologyCellularComponent | G protein-coupled serotonin receptor complex | 1.78e-06 | 4 | 161 | 3 | GO:0098666 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 3.64e-05 | 9 | 161 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | POMT2 NAT8L SRD5A3 MBOAT1 COPB1 DPY19L1 VPS13C PIEZO1 PIGG MYRFL OR52P1 LRIT3 ITPR1 ITPR2 P4HTM LPCAT3 SLC37A2 OR2A25 NR3C2 TMEM39A GRIN3B ATP2A2 PLP2 SOAT2 | 5.44e-05 | 1293 | 161 | 24 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | POMT2 NAT8L SRD5A3 MBOAT1 COPB1 DPY19L1 VPS13C PIEZO1 PIGG MYRFL OR52P1 LRIT3 ITPR1 ITPR2 P4HTM LPCAT3 SLC37A2 OR2A25 NR3C2 TMEM39A GRIN3B ATP2A2 PLP2 SOAT2 | 5.85e-05 | 1299 | 161 | 24 | GO:0098827 |
| GeneOntologyCellularComponent | platelet dense tubular network | 7.07e-05 | 11 | 161 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | POMT2 NAT8L SRD5A3 MBOAT1 COPB1 DPY19L1 VPS13C PIEZO1 PIGG MYRFL OR52P1 LRIT3 ITPR1 ITPR2 P4HTM LPCAT3 SLC37A2 OR2A25 NR3C2 TMEM39A GRIN3B ATP2A2 PLP2 SOAT2 | 8.16e-05 | 1327 | 161 | 24 | GO:0042175 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 5.81e-04 | 5 | 161 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 9.12e-04 | 56 | 161 | 4 | GO:0031234 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 OR11H2 OR2A2 | 1.11e-28 | 691 | 158 | 46 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 OR11H2 OR2A2 | 1.19e-28 | 692 | 158 | 46 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 OR11H2 OR2A2 | 3.40e-28 | 670 | 158 | 45 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 OR2A2 | 5.29e-28 | 677 | 158 | 45 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 CXCR3 OR2A7 GPR17 GPR18 HTR2A HTR2B HTR2C OR6S1 OR4C11 OR6K2 FFAR2 OR1S1 GPR182 OR13F1 GPR85 MC2R OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 CCR3 OR4X2 OR2A2 | 8.70e-28 | 685 | 158 | 45 | PS00237 |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2W5P OR1C1 OR2A5 OR14C36 OR11H12 OR1J2 OR1D2 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR11H2 OR2A2 | 6.37e-26 | 393 | 158 | 35 | IPR000725 |
| Domain | DUF3398 | 1.17e-05 | 6 | 158 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 1.17e-05 | 6 | 158 | 3 | IPR021816 | |
| Domain | Gprotein_alpha_I | 3.22e-05 | 8 | 158 | 3 | IPR001408 | |
| Domain | ARM-type_fold | COPB1 DOCK8 DOCK9 ECPAS ITPR1 ITPR2 EFR3A CSE1L CTNNBL1 PRKDC STAG2 HTT | 3.24e-05 | 339 | 158 | 12 | IPR016024 |
| Domain | 7TM_GPCR_Srsx | 4.68e-05 | 112 | 158 | 7 | SM01381 | |
| Domain | 5HT_rcpt | 4.81e-05 | 9 | 158 | 3 | IPR002231 | |
| Domain | MIR | 6.82e-05 | 10 | 158 | 3 | PF02815 | |
| Domain | MIR_motif | 6.82e-05 | 10 | 158 | 3 | IPR016093 | |
| Domain | MIR | 6.82e-05 | 10 | 158 | 3 | PS50919 | |
| Domain | MIR | 6.82e-05 | 10 | 158 | 3 | SM00472 | |
| Domain | DUF1712 | 7.11e-05 | 2 | 158 | 2 | PF08217 | |
| Domain | DUF1712_fun | 7.11e-05 | 2 | 158 | 2 | IPR013176 | |
| Domain | DHR-1_domain | 9.32e-05 | 11 | 158 | 3 | IPR027007 | |
| Domain | DHR_2 | 9.32e-05 | 11 | 158 | 3 | PS51651 | |
| Domain | DHR_1 | 9.32e-05 | 11 | 158 | 3 | PS51650 | |
| Domain | DHR-2 | 9.32e-05 | 11 | 158 | 3 | PF06920 | |
| Domain | MBOAT | 9.32e-05 | 11 | 158 | 3 | PF03062 | |
| Domain | DOCK | 9.32e-05 | 11 | 158 | 3 | IPR026791 | |
| Domain | MBOAT_fam | 9.32e-05 | 11 | 158 | 3 | IPR004299 | |
| Domain | DOCK_C | 9.32e-05 | 11 | 158 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 9.32e-05 | 11 | 158 | 3 | PF14429 | |
| Domain | DHR-2 | 9.32e-05 | 11 | 158 | 3 | IPR027357 | |
| Domain | ARM-like | COPB1 DOCK8 DOCK10 ECPAS EFR3A CSE1L CTNNBL1 PRKDC STAG2 HTT | 1.03e-04 | 270 | 158 | 10 | IPR011989 |
| Domain | InsP3_rcpt-bd | 2.12e-04 | 3 | 158 | 2 | IPR000493 | |
| Domain | GproteinA_insert | 3.07e-04 | 16 | 158 | 3 | IPR011025 | |
| Domain | - | 3.07e-04 | 16 | 158 | 3 | 1.10.400.10 | |
| Domain | G-alpha | 3.07e-04 | 16 | 158 | 3 | PF00503 | |
| Domain | G_alpha | 3.07e-04 | 16 | 158 | 3 | SM00275 | |
| Domain | Gprotein_alpha_su | 3.70e-04 | 17 | 158 | 3 | IPR001019 | |
| Domain | Pentatricopeptide_repeat | 9.29e-04 | 23 | 158 | 3 | IPR002885 | |
| Domain | RIH_assoc-dom | 1.04e-03 | 6 | 158 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.04e-03 | 6 | 158 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.04e-03 | 6 | 158 | 2 | PF08454 | |
| Domain | RIH_dom | 1.04e-03 | 6 | 158 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.04e-03 | 6 | 158 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.04e-03 | 6 | 158 | 2 | IPR015925 | |
| Domain | - | 1.04e-03 | 6 | 158 | 2 | 1.25.10.30 | |
| Domain | FAT | 1.04e-03 | 6 | 158 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.04e-03 | 6 | 158 | 2 | IPR003151 | |
| Domain | RYDR_ITPR | 1.04e-03 | 6 | 158 | 2 | PF01365 | |
| Domain | AC_N | 1.93e-03 | 8 | 158 | 2 | IPR032628 | |
| Domain | Adcy | 1.93e-03 | 8 | 158 | 2 | IPR030672 | |
| Domain | AC_N | 1.93e-03 | 8 | 158 | 2 | PF16214 | |
| Domain | - | 2.86e-03 | 222 | 158 | 7 | 1.25.10.10 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1C1 OR2A5 OR14C36 ADCY3 OR1J2 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR2A2 | 5.07e-24 | 389 | 121 | 33 | M14091 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1C1 OR2A5 OR14C36 ADCY3 OR1J2 OR1D2 OR51F1 OR51G2 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR11H2 OR2A2 | 4.65e-23 | 417 | 121 | 33 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 OR5D16 OR2A14 TRPM4 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1C1 OR2A5 OR14C36 ADCY3 OR1J2 OR1D2 OR51F1 OR51G2 OR51E1 OR4M2 TAS2R1 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR4C46 GNAT3 OR6Y1 OR2A25 OR4C13 OR4X2 GNAT1 OR11H2 OR2A2 | 2.94e-21 | 636 | 121 | 37 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | OR2F2 CXCR3 GPR17 GPR18 HTR2A HTR2B HTR2C FFAR2 GPR85 MC2R OR1C1 OR1D2 OR2A4 CCR3 | 4.85e-08 | 260 | 121 | 14 | M39397 |
| Pathway | KEGG_GAP_JUNCTION | 1.01e-06 | 90 | 121 | 8 | M4013 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR3 GPR17 GPR18 HTR2A HTR2B HTR2C FFAR2 MC2R PLEKHG5 ADCY3 ADCY5 ITPR1 ITPR2 TAS2R1 GNAT3 CCR3 GNAT1 GNAT2 | 9.62e-06 | 646 | 121 | 18 | MM14962 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | CXCR3 GPR17 GPR18 ADCY3 ADCY5 ITPR1 ITPR2 TAS2R1 GNAT3 CCR3 GNAT1 GNAT2 | 1.62e-05 | 314 | 121 | 12 | M600 |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 2.25e-05 | 20 | 121 | 4 | M39485 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CXCR3 GPR17 GPR18 HTR2A HTR2B HTR2C FFAR2 MC2R PLEKHG5 ADCY3 ADCY5 ITPR1 ITPR2 TAS2R1 GNAT3 CCR3 GNAT1 GNAT2 | 2.93e-05 | 702 | 121 | 18 | M746 |
| Pathway | BIOCARTA_NKT_PATHWAY | 6.67e-05 | 26 | 121 | 4 | M4047 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 6.67e-05 | 50 | 121 | 5 | M47951 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 9.68e-05 | 11 | 121 | 3 | MM15008 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 9.69e-05 | 54 | 121 | 5 | M26911 | |
| Pathway | WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION | 1.04e-04 | 29 | 121 | 4 | M39797 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.28e-04 | 12 | 121 | 3 | M6034 | |
| Pathway | WP_GPCRS_OTHER | 1.46e-04 | 93 | 121 | 6 | M39629 | |
| Pathway | BIOCARTA_NKT_PATHWAY | 1.54e-04 | 32 | 121 | 4 | MM1492 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.91e-04 | 289 | 121 | 10 | MM15057 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.10e-04 | 14 | 121 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 2.10e-04 | 14 | 121 | 3 | M750 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 4.09e-04 | 41 | 121 | 4 | M512 | |
| Pathway | WP_GPCRS_NONODORANT | 4.75e-04 | 266 | 121 | 9 | MM15843 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 7.18e-04 | 5 | 121 | 2 | M49000 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.57e-04 | 178 | 121 | 7 | M2890 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.64e-04 | 23 | 121 | 3 | M47676 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.05e-03 | 90 | 121 | 5 | M6467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.07e-03 | 6 | 121 | 2 | M47960 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2A5 OR14C36 OR52P1 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR2A2 | 5.44e-28 | 340 | 163 | 29 | 11875048 |
| Pubmed | OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2A5 OR14C36 OR52P1 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR2A2 | 7.02e-28 | 343 | 163 | 29 | 32295537 | |
| Pubmed | OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2A5 OR14C36 OR52P1 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR2A2 | 9.03e-28 | 346 | 163 | 29 | 14611657 | |
| Pubmed | OR5D16 OR2A14 OR2F2 OR2A7 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR2A5 OR14C36 OR52P1 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR2A4 OR51I2 OR52D1 OR4C46 OR6Y1 OR2A25 OR4C13 OR4X2 OR2A2 | 1.29e-26 | 340 | 163 | 28 | 11802173 | |
| Pubmed | OR5D16 OR2A14 OR2F2 OR2A7 OR6S1 OR4C11 OR6K2 OR1S1 OR13F1 OR1F2P OR1C1 OR14C36 OR52P1 OR1J2 OR1D2 OR51F1 OR51G2 OR52B4 OR51E1 OR4M2 OR13D1 OR11H1 OR2A4 OR51I2 OR52D1 OR6Y1 OR4C13 OR4X2 OR11H2 OR2A2 | 1.92e-23 | 541 | 163 | 30 | 14983052 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | OR5D16 OR2A14 OR2A7 OR1F2P OR2W5P OR1C1 OR2A5 OR1J2 OR1D2 OR11H1 OR4C13 OR4X2 OR2A2 | 4.20e-11 | 219 | 163 | 13 | 12213199 |
| Pubmed | Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. | 1.01e-07 | 3 | 163 | 3 | 28258217 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18703043 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 15831837 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 7582481 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 24089568 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19057895 | ||
| Pubmed | Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. | 1.01e-07 | 3 | 163 | 3 | 10627607 | |
| Pubmed | Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo. | 1.01e-07 | 3 | 163 | 3 | 10978843 | |
| Pubmed | Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. | 1.01e-07 | 3 | 163 | 3 | 1381232 | |
| Pubmed | MAN2A1 COPB1 DPY19L1 DOCK8 DOCK9 DOCK10 PIGG ECPAS ADCY3 ITPR1 ITPR2 SLC44A1 CSE1L LPCAT3 PES1 CTNNBL1 GEMIN4 PRKDC CMTM7 STAG2 GOLGB1 | 1.48e-07 | 1168 | 163 | 21 | 19946888 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 11150294 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 6.16e-07 | 35 | 163 | 5 | 16939646 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | POMT2 MAN2A1 DPY19L1 PODXL PIEZO1 ST3GAL2 PIGG ITPR1 ITPR2 TGFB2 SNX14 P4HTM RUVBL1 BRI3BP LPCAT3 PES1 SCAPER CD70 ATP2A2 HTT | 9.86e-07 | 1201 | 163 | 20 | 35696571 |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 9165122 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 8833759 | ||
| Pubmed | 2.56e-06 | 128 | 163 | 7 | 30995482 | ||
| Pubmed | 5.04e-06 | 200 | 163 | 8 | 18240029 | ||
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 26053401 | ||
| Pubmed | The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. | 1.18e-05 | 10 | 163 | 3 | 8521505 | |
| Pubmed | Multiplicity of mechanisms of serotonin receptor signal transduction. | 2.16e-05 | 12 | 163 | 3 | 11916537 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24244317 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 2534964 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16517693 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16382194 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28962833 | ||
| Pubmed | Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network. | 2.18e-05 | 2 | 163 | 2 | 21789169 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15201137 | ||
| Pubmed | GEMIN4 functions as a coregulator of the mineralocorticoid receptor. | 2.18e-05 | 2 | 163 | 2 | 25555524 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 2.18e-05 | 2 | 163 | 2 | 23582047 | |
| Pubmed | A protein interaction mechanism for suppressing the mechanosensitive Piezo channels. | 2.18e-05 | 2 | 163 | 2 | 29176668 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18336767 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25602134 | ||
| Pubmed | Functional interchangeability of rod and cone transducin alpha-subunits. | 2.18e-05 | 2 | 163 | 2 | 19815523 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12379596 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19142110 | ||
| Pubmed | CXC and CC chemokine receptors on coronary and brain endothelia. | 2.18e-05 | 2 | 163 | 2 | 10666479 | |
| Pubmed | 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. | 2.18e-05 | 2 | 163 | 2 | 19322172 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16683905 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8401589 | ||
| Pubmed | Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. | 2.18e-05 | 2 | 163 | 2 | 16258205 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12970106 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 2.18e-05 | 2 | 163 | 2 | 19120126 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 37768455 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21118683 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15562295 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38098265 | ||
| Pubmed | Depression in Alzheimer's disease: the effect of serotonin receptor gene variation. | 2.18e-05 | 2 | 163 | 2 | 12707936 | |
| Pubmed | Unified approach to the analysis of genetic variation in serotonergic pathways. | 2.18e-05 | 2 | 163 | 2 | 10581480 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12454564 | ||
| Pubmed | Adaptation to background light enables contrast coding at rod bipolar cell synapses. | 2.18e-05 | 2 | 163 | 2 | 24373883 | |
| Pubmed | Diminished Cone Sensitivity in cpfl3 Mice Is Caused by Defective Transducin Signaling. | 2.18e-05 | 2 | 163 | 2 | 32315379 | |
| Pubmed | Regulation of serotonin-2C receptor G-protein coupling by RNA editing. | 2.18e-05 | 2 | 163 | 2 | 9153397 | |
| Pubmed | 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes. | 2.18e-05 | 2 | 163 | 2 | 23346101 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16741915 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24770757 | ||
| Pubmed | Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha -subunit. | 2.18e-05 | 2 | 163 | 2 | 11095744 | |
| Pubmed | Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice. | 2.18e-05 | 2 | 163 | 2 | 21340474 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9419219 | ||
| Pubmed | Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. | 2.18e-05 | 2 | 163 | 2 | 1722404 | |
| Pubmed | Dark light, rod saturation, and the absolute and incremental sensitivity of mouse cone vision. | 2.18e-05 | 2 | 163 | 2 | 20844144 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15862800 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 18708078 | ||
| Pubmed | Speed, spatial, and temporal tuning of rod and cone vision in mouse. | 2.18e-05 | 2 | 163 | 2 | 18171936 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31787571 | ||
| Pubmed | Umami taste responses are mediated by alpha-transducin and alpha-gustducin. | 2.18e-05 | 2 | 163 | 2 | 15342734 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17625040 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17098333 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22397586 | ||
| Pubmed | Robust visual cortex evoked potentials (VEP) in Gnat1 and Gnat2 knockout mice. | 2.18e-05 | 2 | 163 | 2 | 36605613 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20846463 | ||
| Pubmed | New mouse 5-HT2-like receptor. Expression in brain, heart and intestine. | 2.18e-05 | 2 | 163 | 2 | 1426253 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23537943 | ||
| Pubmed | Rod Photoreceptors Avoid Saturation in Bright Light by the Movement of the G Protein Transducin. | 2.18e-05 | 2 | 163 | 2 | 33593858 | |
| Pubmed | Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome. | 2.18e-05 | 2 | 163 | 2 | 28494446 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12097814 | ||
| Pubmed | Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. | 2.18e-05 | 2 | 163 | 2 | 9241279 | |
| Pubmed | Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. | 2.18e-05 | 2 | 163 | 2 | 8626761 | |
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.64e-05 | 74 | 163 | 5 | 15081110 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | TRPM4 GPR17 HTR2B HTR2C GPR182 MC2R PIGG KLHL22 P4HTM YIPF1 ATP2A2 GOLGB1 HTT | 2.72e-05 | 697 | 163 | 13 | 28298427 |
| Pubmed | 2.79e-05 | 13 | 163 | 3 | 22569571 | ||
| Pubmed | Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein. | 2.79e-05 | 13 | 163 | 3 | 8208289 | |
| Pubmed | 2.79e-05 | 13 | 163 | 3 | 22640814 | ||
| Pubmed | Genetic evaluation of the serotonergic system in chronic fatigue syndrome. | 2.79e-05 | 13 | 163 | 3 | 18079067 | |
| Pubmed | Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. | 2.79e-05 | 13 | 163 | 3 | 16892066 | |
| Pubmed | 3.03e-05 | 38 | 163 | 4 | 22908908 | ||
| Pubmed | 3.54e-05 | 14 | 163 | 3 | 12432077 | ||
| Pubmed | 4.41e-05 | 15 | 163 | 3 | 11118617 | ||
| Pubmed | 6.51e-05 | 46 | 163 | 4 | 32126975 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 10874040 | ||
| Pubmed | Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. | 6.53e-05 | 3 | 163 | 2 | 12759158 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 20395455 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 12761567 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 28212864 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 19439249 | ||
| Interaction | GPR17 interactions | GPR17 PIGG ECPAS ITPR2 CSE1L LPCAT3 GEMIN4 PRKDC ATP2A2 STAG2 HTT DOP1A | 4.28e-07 | 283 | 134 | 12 | int:GPR17 |
| Cytoband | 11p15.4 | OR51A4 OR51A2 DNHD1 OR52P1 OR51F1 OR51G2 OR52B4 OR51E1 OR51I2 OR52D1 | 3.03e-09 | 200 | 163 | 10 | 11p15.4 |
| Cytoband | 7q35 | 4.58e-08 | 55 | 163 | 6 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.39e-07 | 66 | 163 | 6 | chr7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | OR51A4 OR51A2 DNHD1 COPB1 OR52P1 OR51F1 OR51G2 OR52B4 OR51E1 OR51I2 OR52D1 | 6.23e-06 | 564 | 163 | 11 | chr11p15 |
| GeneFamily | Olfactory receptors, family 51 | 3.73e-07 | 44 | 117 | 6 | 164 | |
| GeneFamily | Olfactory receptors, family 2 | 7.02e-07 | 113 | 117 | 8 | 149 | |
| GeneFamily | Olfactory receptors, family 1 | 5.72e-06 | 40 | 117 | 5 | 147 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 7.20e-05 | 13 | 117 | 3 | 170 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.24e-04 | 3 | 117 | 2 | 297 | |
| GeneFamily | Olfactory receptors, family 11 | 4.26e-04 | 23 | 117 | 3 | 159 | |
| GeneFamily | Membrane bound O-acyltransferases | 8.54e-04 | 7 | 117 | 2 | 1036 | |
| GeneFamily | Olfactory receptors, family 4 | 1.51e-03 | 129 | 117 | 5 | 151 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.64e-03 | 78 | 117 | 4 | 262 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.81e-03 | 10 | 117 | 2 | 53 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.23e-03 | 206 | 117 | 6 | 682 | |
| GeneFamily | Olfactory receptors, family 52 | 3.92e-03 | 49 | 117 | 3 | 165 | |
| GeneFamily | Olfactory receptors, family 6 | 4.39e-03 | 51 | 117 | 3 | 153 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-06 | 173 | 159 | 7 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.00e-06 | 173 | 159 | 7 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 179 | 159 | 7 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-06 | 179 | 159 | 7 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.11e-06 | 122 | 159 | 6 | 032b5da8befcb1a159245f8d0c67f91795883ee0 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.53e-06 | 199 | 159 | 7 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-05 | 167 | 159 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 172 | 159 | 6 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.60e-05 | 172 | 159 | 6 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 172 | 159 | 6 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 172 | 159 | 6 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 174 | 159 | 6 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-05 | 174 | 159 | 6 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.09e-05 | 176 | 159 | 6 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.09e-05 | 176 | 159 | 6 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-05 | 178 | 159 | 6 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-05 | 178 | 159 | 6 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 178 | 159 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 178 | 159 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 181 | 159 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-05 | 185 | 159 | 6 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 187 | 159 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.73e-05 | 187 | 159 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| Computational | Neighborhood of PAX7 | 1.85e-05 | 266 | 77 | 10 | MORF_PAX7 | |
| Computational | Neighborhood of NOS2A | 3.66e-05 | 288 | 77 | 10 | MORF_NOS2A | |
| Computational | Genes in the cancer module 146. | 8.66e-05 | 102 | 77 | 6 | MODULE_146 | |
| Computational | Neighborhood of IL13 | 2.58e-04 | 234 | 77 | 8 | MORF_IL13 | |
| Computational | Neighborhood of FOSL1 | 6.04e-04 | 406 | 77 | 10 | MORF_FOSL1 | |
| Computational | Neighborhood of MAGEA9 | GPR18 HTR2C UBE4B TRIM24 ADCY3 TENM4 SCAPER CCR3 NR3C2 SOAT2 | 8.29e-04 | 423 | 77 | 10 | MORF_MAGEA9 |
| Computational | Neighborhood of MDM2 | 8.31e-04 | 279 | 77 | 8 | MORF_MDM2 | |
| Computational | Neighborhood of CAMK4 | 1.07e-03 | 290 | 77 | 8 | MORF_CAMK4 | |
| Computational | Neighborhood of ESR1 | 1.43e-03 | 172 | 77 | 6 | MORF_ESR1 | |
| Computational | Neighborhood of ARL3 | 1.44e-03 | 304 | 77 | 8 | MORF_ARL3 | |
| Computational | Neighborhood of IL16 | 1.58e-03 | 239 | 77 | 7 | MORF_IL16 | |
| Computational | Neighborhood of RAD51L3 | 1.72e-03 | 387 | 77 | 9 | MORF_RAD51L3 | |
| Computational | Neighborhood of BCL2L11 | 2.12e-03 | 186 | 77 | 6 | MORF_BCL2L11 | |
| Computational | Neighborhood of SUPT3H | 2.33e-03 | 328 | 77 | 8 | MORF_SUPT3H | |
| Computational | Neighborhood of BNIP1 | 2.36e-03 | 190 | 77 | 6 | MORF_BNIP1 | |
| Drug | YM348 | 2.97e-08 | 14 | 159 | 5 | CID003045225 | |
| Drug | Me-M | 3.34e-07 | 3 | 159 | 3 | CID000077590 | |
| Drug | Norfenfluramine | 3.34e-07 | 3 | 159 | 3 | ctd:D009642 | |
| Drug | seganserin | 4.65e-07 | 10 | 159 | 4 | CID000071767 | |
| Drug | cisapride | 1.22e-06 | 112 | 159 | 8 | CID000002769 | |
| Drug | (ch3)2cnh2 | 1.33e-06 | 4 | 159 | 3 | CID000520257 | |
| Drug | PIM-35 | 1.33e-06 | 4 | 159 | 3 | CID000195658 | |
| Drug | 2-aminopropane hydrochloride | 1.33e-06 | 4 | 159 | 3 | CID000027399 | |
| Drug | Tegaserod | 1.33e-06 | 4 | 159 | 3 | DB01079 | |
| Drug | compound 4d | 2.17e-06 | 14 | 159 | 4 | CID000448577 | |
| Drug | butyranilide | 3.31e-06 | 5 | 159 | 3 | CID000014323 | |
| Drug | Methysergide | 3.31e-06 | 5 | 159 | 3 | DB00247 | |
| Drug | SB221284 | 3.31e-06 | 5 | 159 | 3 | CID000443389 | |
| Drug | SB 242084 | 6.49e-06 | 18 | 159 | 4 | CID003644637 | |
| Drug | Clomipramine | 6.58e-06 | 6 | 159 | 3 | DB01242 | |
| Drug | Dmipap | 6.58e-06 | 6 | 159 | 3 | CID000126620 | |
| Drug | Sch-38548 | 6.58e-06 | 6 | 159 | 3 | CID000130519 | |
| Drug | BrAcTFMPP | 6.58e-06 | 6 | 159 | 3 | CID000146887 | |
| Drug | SB 200646A | 8.18e-06 | 19 | 159 | 4 | CID000126769 | |
| Drug | MDL 11,939 | 8.18e-06 | 19 | 159 | 4 | CID000071781 | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.31e-06 | 194 | 159 | 9 | 5418_UP | |
| Drug | phenylpiperazine | 9.54e-06 | 41 | 159 | 5 | CID000007096 | |
| Drug | LY215840 | 1.15e-05 | 7 | 159 | 3 | CID000132049 | |
| Drug | 3,4-Methylenedioxymethamphetamine | 1.15e-05 | 7 | 159 | 3 | DB01454 | |
| Drug | Fenfluramine | 1.15e-05 | 7 | 159 | 3 | ctd:D005277 | |
| Drug | SB 206553 | 1.15e-05 | 7 | 159 | 3 | ctd:C094868 | |
| Drug | oracaine | 1.15e-05 | 7 | 159 | 3 | CID000004065 | |
| Drug | urea HCl | 1.15e-05 | 7 | 159 | 3 | CID000101721 | |
| Drug | dibenzosuberane | 1.15e-05 | 7 | 159 | 3 | CID000070029 | |
| Drug | ziram | 1.25e-05 | 21 | 159 | 4 | CID000008722 | |
| Drug | medifoxamine | 1.82e-05 | 8 | 159 | 3 | CID000036109 | |
| Drug | SB 216641 | 1.82e-05 | 8 | 159 | 3 | CID003292447 | |
| Drug | amesergide | 1.82e-05 | 8 | 159 | 3 | CID000060740 | |
| Drug | agomelatine | 1.83e-05 | 23 | 159 | 4 | CID000082148 | |
| Drug | oxymetazoline | 1.93e-05 | 79 | 159 | 6 | CID000004636 | |
| Drug | AC1Q7BEJ | 2.56e-05 | 50 | 159 | 5 | CID000001224 | |
| Drug | NIASP | 2.72e-05 | 9 | 159 | 3 | CID006439184 | |
| Drug | Minaprine | 2.72e-05 | 9 | 159 | 3 | DB00805 | |
| Drug | iodoLSD | 2.72e-05 | 9 | 159 | 3 | CID000151142 | |
| Drug | M100907 | 2.83e-05 | 51 | 159 | 5 | CID000060858 | |
| Drug | 5-methoxytryptamine | 3.74e-05 | 54 | 159 | 5 | CID000001833 | |
| Drug | Ritanserin | 3.87e-05 | 10 | 159 | 3 | ctd:D016713 | |
| Drug | LY344864 | 3.87e-05 | 10 | 159 | 3 | CID005311097 | |
| Drug | 5-CT | 4.09e-05 | 55 | 159 | 5 | CID000001809 | |
| Drug | L-741,626 | 4.11e-05 | 28 | 159 | 4 | CID000133633 | |
| Drug | Ro 60-0175 | 4.85e-05 | 2 | 159 | 2 | ctd:C103848 | |
| Drug | AC1Q1YRG | 4.85e-05 | 2 | 159 | 2 | CID000105432 | |
| Drug | SB 228357 | 4.85e-05 | 2 | 159 | 2 | ctd:C118947 | |
| Drug | SB-228357 | 4.85e-05 | 2 | 159 | 2 | CID000443390 | |
| Drug | cyanopindolol | 4.87e-05 | 57 | 159 | 5 | CID000155346 | |
| Drug | RS-127445 | 5.29e-05 | 11 | 159 | 3 | CID000196968 | |
| Drug | homophthalimide | 5.29e-05 | 11 | 159 | 3 | CID000349435 | |
| Drug | sulpiride | 5.83e-05 | 96 | 159 | 6 | CID000005355 | |
| Drug | 3-isoreserpine | 5.88e-05 | 190 | 159 | 8 | CID000005052 | |
| Drug | AC1L3P1W | 6.22e-05 | 31 | 159 | 4 | CID000119574 | |
| Drug | ipsapirone | 6.77e-05 | 61 | 159 | 5 | CID000056971 | |
| Drug | BRL15572 | 7.02e-05 | 12 | 159 | 3 | CID003654103 | |
| Drug | Chlorprothixene | 7.02e-05 | 12 | 159 | 3 | DB01239 | |
| Drug | xestospongin C | 7.02e-05 | 12 | 159 | 3 | ctd:C511704 | |
| Drug | imidazolidinone | 7.02e-05 | 12 | 159 | 3 | CID000008453 | |
| Drug | sergolexole | 7.02e-05 | 12 | 159 | 3 | CID000060262 | |
| Drug | RU 24969 | 7.07e-05 | 32 | 159 | 4 | CID000108028 | |
| Drug | CAS 66104-23-2 | 7.91e-05 | 63 | 159 | 5 | CID000004745 | |
| Drug | pindolol | 7.91e-05 | 63 | 159 | 5 | CID000004828 | |
| Drug | Depixol | 8.00e-05 | 33 | 159 | 4 | CID000017011 | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 3264_UP | |
| Drug | S-(-)-Lisuride | 9.19e-05 | 65 | 159 | 5 | CID000003938 | |
| Drug | AC1L1HE1 | 1.06e-04 | 67 | 159 | 5 | CID000004090 | |
| Drug | hallucinogen | 1.13e-04 | 36 | 159 | 4 | CID000031374 | |
| Drug | Lisuride | 1.15e-04 | 14 | 159 | 3 | DB00589 | |
| Drug | Pramipexole | 1.15e-04 | 14 | 159 | 3 | DB00413 | |
| Drug | Ropinirole | 1.15e-04 | 14 | 159 | 3 | DB00268 | |
| Drug | L-694,247 | 1.15e-04 | 14 | 159 | 3 | CID000132059 | |
| Drug | deoxycorticosterone | 1.31e-04 | 111 | 159 | 6 | CID000006166 | |
| Drug | Cabergoline | 1.43e-04 | 15 | 159 | 3 | DB00248 | |
| Drug | Apomorphine | 1.43e-04 | 15 | 159 | 3 | DB00714 | |
| Drug | BMY 42393 | 1.43e-04 | 15 | 159 | 3 | CID000131961 | |
| Drug | dotarizine | 1.43e-04 | 15 | 159 | 3 | CID000055285 | |
| Drug | Fenfluramine | 1.45e-04 | 3 | 159 | 2 | DB00574 | |
| Drug | 9-(2-Deoxy-5-O-Phosphono-Beta-D-Erythro-Pentofuranosyl)-6-(Phosphonooxy)-9h-Purine | 1.45e-04 | 3 | 159 | 2 | CID009549204 | |
| Drug | 6-methoxymianserin | 1.45e-04 | 3 | 159 | 2 | ctd:C461657 | |
| Drug | 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino(2,1-d)pyrrolo(1,2-b) (1,2,5)benzotriazepine | 1.45e-04 | 3 | 159 | 2 | ctd:C507420 | |
| Drug | gamma-mangostin | 1.45e-04 | 3 | 159 | 2 | ctd:C102777 | |
| Drug | spiramide | 1.45e-04 | 3 | 159 | 2 | CID000068186 | |
| Drug | WAY-181187 | 1.45e-04 | 3 | 159 | 2 | CID010150497 | |
| Drug | ketanserinol | 1.45e-04 | 3 | 159 | 2 | CID000156394 | |
| Drug | EEDQ | 1.50e-04 | 72 | 159 | 5 | CID000027833 | |
| Drug | SCH 23390 | 1.66e-04 | 116 | 159 | 6 | CID000005018 | |
| Drug | carbidine | 1.72e-04 | 40 | 159 | 4 | CID000065684 | |
| Drug | 8-OH-DPAT | 1.74e-04 | 117 | 159 | 6 | CID000001220 | |
| Drug | 1-(3-chlorophenyl)piperazine | 1.75e-04 | 16 | 159 | 3 | ctd:C015068 | |
| Drug | piperazine dihydrochloride | 1.75e-04 | 16 | 159 | 3 | CID000008893 | |
| Drug | Mp2589 | 1.82e-04 | 75 | 159 | 5 | CID003073497 | |
| Drug | 4,4'-bisphenol F | 1.93e-04 | 76 | 159 | 5 | ctd:C008745 | |
| Drug | AC1L1H5B | 2.05e-04 | 77 | 159 | 5 | CID000003981 | |
| Drug | methiothepin | 2.05e-04 | 77 | 159 | 5 | CID000004106 | |
| Drug | 5-methyltryptamine | 2.11e-04 | 17 | 159 | 3 | CID000015760 | |
| Drug | Pergolide | 2.11e-04 | 17 | 159 | 3 | DB01186 | |
| Drug | San 21009 | 2.11e-04 | 17 | 159 | 3 | CID000152662 | |
| Drug | zatosetron | 2.11e-04 | 17 | 159 | 3 | CID000060763 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 6.53e-06 | 8 | 146 | 3 | DOID:1858 (implicated_via_orthology) | |
| Disease | Hypoxic Brain Damage | 2.43e-05 | 2 | 146 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 2.43e-05 | 2 | 146 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 2.43e-05 | 2 | 146 | 2 | C1527348 | |
| Disease | Anoxia of brain | 2.43e-05 | 2 | 146 | 2 | C0995195 | |
| Disease | major depressive disorder (implicated_via_orthology) | 7.27e-05 | 3 | 146 | 2 | DOID:1470 (implicated_via_orthology) | |
| Disease | Hereditary bundle branch system defect | 1.45e-04 | 4 | 146 | 2 | C1879286 | |
| Disease | glucose tolerance test | 3.18e-04 | 27 | 146 | 3 | EFO_0004307 | |
| Disease | Ventricular Dysfunction, Left | 4.37e-04 | 30 | 146 | 3 | C0242698 | |
| Disease | COVID-19, obesity | 5.02e-04 | 7 | 146 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | Profound Mental Retardation | 6.54e-04 | 139 | 146 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.54e-04 | 139 | 146 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.54e-04 | 139 | 146 | 5 | C0917816 | |
| Disease | cardiac arrest (biomarker_via_orthology) | 6.68e-04 | 8 | 146 | 2 | DOID:0060319 (biomarker_via_orthology) | |
| Disease | lymphocyte count | MBOAT1 UBE4B RB1 PIEZO1 KIF1B DOCK10 HKDC1 OR2W5P CPXCR1 CPS1 ADCY5 ITPR1 ITPR2 TENM4 DNAH17 NR3C2 HTT | 9.51e-04 | 1464 | 146 | 17 | EFO_0004587 |
| Disease | depressive symptom measurement, response to antidepressant | 9.72e-04 | 88 | 146 | 4 | EFO_0007006, GO_0036276 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 9.78e-04 | 152 | 146 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ulcerative colitis (is_marker_for) | 1.03e-03 | 40 | 146 | 3 | DOID:8577 (is_marker_for) | |
| Disease | urate measurement, bone density | HTR2A MBOAT1 UBE4B PODXL ITPR1 ITPR2 OR1D2 CNTNAP5 NR3C2 PRKDC | 1.06e-03 | 619 | 146 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Combined immunodeficiency | 1.10e-03 | 41 | 146 | 3 | C0494261 | |
| Disease | Neurodevelopmental Disorders | 1.19e-03 | 93 | 146 | 4 | C1535926 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 1.30e-03 | 11 | 146 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | Mood Disorders | 1.52e-03 | 168 | 146 | 5 | C0525045 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.55e-03 | 12 | 146 | 2 | C3501847 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.55e-03 | 12 | 146 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.55e-03 | 12 | 146 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.55e-03 | 12 | 146 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.55e-03 | 12 | 146 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.55e-03 | 12 | 146 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.55e-03 | 12 | 146 | 2 | C1848172 | |
| Disease | Mental Depression | 1.71e-03 | 254 | 146 | 6 | C0011570 | |
| Disease | Intellectual Disability | 1.78e-03 | 447 | 146 | 8 | C3714756 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.83e-03 | 13 | 146 | 2 | C4041558 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 2.13e-03 | 14 | 146 | 2 | DOID:841 (is_marker_for) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 2.13e-03 | 14 | 146 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.45e-03 | 15 | 146 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.45e-03 | 15 | 146 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.45e-03 | 15 | 146 | 2 | C0154091 | |
| Disease | unipolar depression, response to escitalopram, response to citalopram, mood disorder | 2.45e-03 | 15 | 146 | 2 | EFO_0003761, EFO_0004247, EFO_0006329, EFO_0007871 | |
| Disease | isoleucine measurement | 2.72e-03 | 56 | 146 | 3 | EFO_0009793 | |
| Disease | transferrin saturation measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0006333 | |
| Disease | anthranilic acid measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0010460 | |
| Disease | Seasonal Affective Disorder | 2.79e-03 | 16 | 146 | 2 | C0085159 | |
| Disease | retinopathy | 3.15e-03 | 17 | 146 | 2 | EFO_0003839 | |
| Disease | Night blindness, congenital stationary | 3.15e-03 | 17 | 146 | 2 | C0339535 | |
| Disease | hyperglycemia (implicated_via_orthology) | 3.15e-03 | 17 | 146 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | Depressive disorder | 3.24e-03 | 289 | 146 | 6 | C0011581 | |
| Disease | Carcinoma of bladder | 3.53e-03 | 18 | 146 | 2 | C0699885 | |
| Disease | thrombin activatable fibrinolysis inhibitor activation peptide measurement | 3.93e-03 | 19 | 146 | 2 | EFO_0008582 | |
| Disease | BRCAX breast cancer | 4.36e-03 | 20 | 146 | 2 | EFO_0009443 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IICIEMFLAAIAHHY | 296 | Q9NVA4 | |
| MAYCYAHILAVLLVS | 231 | P49682 | |
| ASIMHLCAISVDRYI | 141 | P41595 | |
| TILYRFLTNEVVHMC | 31 | A6NH57 | |
| VRVVLFSMSCVYILH | 161 | Q8WY22 | |
| LDAGLFVLQHICYIM | 486 | Q8WYA6 | |
| LFHETGMAFITYVCV | 2091 | Q86UK0 | |
| VFLMHLAVADLSCVL | 96 | Q13304 | |
| FIMIGCYLVIIHNLL | 201 | Q14330 | |
| VALACMIVIFLTIAY | 631 | Q9UNQ0 | |
| ASIMHLCAISLDRYV | 161 | P28223 | |
| SIMHLCAISLDRYVA | 141 | P28335 | |
| EHAAIYLTACMESLF | 231 | A6QL63 | |
| YFALCLSLMVVSLLE | 311 | Q8WXA8 | |
| LSEVLAHLLDMVFYS | 2041 | Q5JWR5 | |
| IIMSLESVLYGVCAH | 1341 | Q96M86 | |
| DHMGLACYALIAVVL | 296 | O95622 | |
| DGIYMVHIQVTLAIC | 101 | P32970 | |
| EFAVHCFKIIMYSIQ | 271 | Q14156 | |
| MILHLLCDRYFSQAA | 151 | Q8N123 | |
| CSRAYFLVLMVFVHL | 56 | Q9NXG6 | |
| DLVISFQLMLCVLDY | 211 | P06400 | |
| SFERLLLHAVCQYMD | 216 | Q96D70 | |
| LLHAVCQYMDLISAS | 221 | Q96D70 | |
| VCLLTVMAFDHYLAI | 111 | Q8NGY2 | |
| AYVLVCMLGLFVHEF | 2351 | Q14571 | |
| VTELILFAVMAYDHF | 111 | Q8NGK9 | |
| ISVVCLIALLMSYAF | 206 | A0A0X1KG70 | |
| LFLIYEHRTSCLLFM | 476 | P05546 | |
| LAQMFCVHSIYALES | 101 | Q9H346 | |
| IVCMASFLLLVAALY | 466 | O00592 | |
| HYTVIMREELCVFLV | 131 | Q8NGS2 | |
| LLLGTMAYDHFVAIC | 126 | Q8NH92 | |
| ECLLLTVMAFDQYLA | 126 | Q8NH07 | |
| CIMQTFLYLAFAHVE | 96 | Q96R47 | |
| FAHVECLILVVMSYD | 106 | Q96R47 | |
| MSFGHCTIVIIVQYL | 136 | O15552 | |
| IIFCAALSAYDMVLV | 221 | A8MTJ3 | |
| HMAAQCLALLLYFQL | 146 | Q8NG48 | |
| MHDLVSDLLEFCFYT | 931 | P08235 | |
| CVVIFSLYLMLDRGH | 16 | Q16706 | |
| CIIFIAALSAYDMVL | 216 | P11488 | |
| LMYHIHLVELLAVCT | 1381 | Q14643 | |
| CSLFYTMESLRELHI | 626 | P59045 | |
| IYMTLSAYLELDHCI | 1381 | O60333 | |
| ICIAIIMVGIFSTHY | 631 | Q99665 | |
| LLVLAIMYVFASHHF | 1196 | Q9NRD8 | |
| VHKCYIFLVFMVVIL | 491 | Q9P1W3 | |
| AFGEIVLYLRMCLAH | 591 | Q5VYK3 | |
| MHRLIFVYTLICANF | 1 | Q9GZP0 | |
| LFLTIMAHDRYVAVC | 111 | Q8NHC7 | |
| ILLTVMAYDHYVAIC | 111 | A6NHA9 | |
| VLLAMAFDRYVAICH | 116 | Q8TCB6 | |
| ECVLLVVMSHDRYVA | 111 | A6NFC9 | |
| AVAFFYIHMLSLSLV | 256 | A6NGY5 | |
| CVSHICAVLLFYTPM | 246 | Q8NGK0 | |
| CVSHILAVLAFYVPM | 241 | Q9H344 | |
| ILLVMAFDHYIAICY | 116 | Q8NGK2 | |
| ISVVCLIALLMSYAF | 206 | Q8NGB6 | |
| LLTVMAYDHYVAICK | 106 | Q8NGF9 | |
| CVVLSDIHIDIMDYI | 816 | P53618 | |
| IIYIHMISLALCFVL | 286 | Q2PZI1 | |
| MAFCALTIVALYILS | 636 | Q96LU7 | |
| LHSGYLVCFQMEFLI | 376 | Q6P1A2 | |
| LVYLMLAFCHLSEQC | 781 | Q96MN2 | |
| MHLFACLCIVLSFLE | 1 | Q3SXY7 | |
| MKYVHPFIFALCTII | 471 | Q07864 | |
| FLMIVSAYIVAVYHC | 1996 | Q07864 | |
| FAVTECLLLVVMSYD | 106 | Q96R45 | |
| EFVLLAVMAYDRHVA | 111 | O95006 | |
| LCLMVDFILIAVSYT | 206 | Q8NGJ7 | |
| LCLMVDFILIAVSYT | 206 | Q8NGJ6 | |
| ALHLFGCMEIFVLIL | 101 | Q6IEV9 | |
| ILLTVMAYDHYVAIC | 111 | Q8NGP0 | |
| VIDHFMCDLYTLINL | 171 | Q8NGP0 | |
| VYLFLCMLSTIDLAA | 61 | Q8NH57 | |
| VLLAMAFDRYVAICH | 116 | Q8NH57 | |
| VLHVLCAIYMFYALA | 111 | Q9HC58 | |
| AIFFVVYMCDLHTKI | 61 | Q04941 | |
| LCLLASYMHITCVVL | 211 | Q96R84 | |
| FAVTECLILVVMSYD | 106 | Q6IF42 | |
| FAVTECLLLVVMSYD | 106 | O95047 | |
| TFLYMAFAHTECLIL | 101 | Q96R48 | |
| ECLYVSVFSNVMIHV | 146 | Q9H8P0 | |
| LLAVMSADRYLAICH | 116 | Q8NH40 | |
| LIFMICVAYHSQLEI | 856 | Q9Y2I7 | |
| CVAYHSQLEISFLMD | 861 | Q9Y2I7 | |
| NVFYMLISADVLACL | 461 | Q8TED4 | |
| ICLSMSLHFLILYVE | 936 | P16615 | |
| FALHPTSMEYCIIEV | 701 | P31327 | |
| QQHVLVMCATAFYLI | 2826 | P42858 | |
| MCQILHFIYTSELEL | 101 | Q53GT1 | |
| LSEAAMCYIHIAALI | 1716 | Q96BY6 | |
| MCYIHIAALIAEYLK | 1721 | Q96BY6 | |
| VHAAALVAEYLSMLE | 1666 | Q8NF50 | |
| MCYVHVTALVAEYLT | 1636 | Q9BZ29 | |
| LVYCFAFLTEMVHFI | 286 | Q8WUS8 | |
| LVMLVTEVIAYSHCC | 281 | P51677 | |
| ITFHDHALMIIFLIC | 21 | P00403 | |
| HALMIIFLICFLVLY | 26 | P00403 | |
| MLFALCYFHAVVAER | 4026 | Q9UFH2 | |
| ELHLIVYKAMSAAVC | 311 | P86791 | |
| ELHLIVYKAMSAAVC | 311 | P86790 | |
| VAAMVLLSVVFCLYF | 21 | A6NFZ4 | |
| LVVFAALFDCYVVVM | 81 | O60266 | |
| TVILHCMYTDVVDLS | 326 | Q9P203 | |
| HLFVLVLMCYAIMVT | 86 | Q6ZNC8 | |
| MLFCISVTRYLAIAH | 111 | P60893 | |
| LVAHCFLSIYEMVVD | 581 | Q8WWI5 | |
| FLSIYEMVVDVLFLC | 586 | Q8WWI5 | |
| QATDLAGVLHMLYCV | 1176 | Q9BY12 | |
| IFCIIGIMTRFLYQH | 1251 | Q8WYK1 | |
| VMDVVEVIHCLTALY | 441 | Q13474 | |
| MIIETLNLYFHIQCF | 1026 | Q9UPQ0 | |
| AEQQHLLSVLFLCMY | 21 | Q15619 | |
| ECLLLTVMAFDQYLA | 126 | Q8NG94 | |
| ECLLLTVMAFDQYLA | 126 | B2RN74 | |
| FAHTECLLLVVMSYD | 106 | A4D2G3 | |
| SRKIHYIFCEMYVLL | 171 | P34982 | |
| LLAVMAYDHYVAICN | 146 | Q8NGV5 | |
| CTAHLMVVVLFYGTA | 241 | Q8NGS4 | |
| MSIYHFAGLFVLLCL | 826 | O60391 | |
| LYLFSIFAIAECHML | 101 | P0DMU2 | |
| ILLHDAYMFCIIDKS | 596 | Q969X6 | |
| FVCSTCHELLVDMIY | 266 | Q9UGI8 | |
| YHACGVIATIAFLMI | 56 | O95807 | |
| LALYTATFAVHFMVL | 291 | Q9UKY4 | |
| HIVQCIADFLDYMGL | 576 | Q2TB90 | |
| LMHTYAGLAVICALI | 401 | Q7RTX9 | |
| IIFCAALSAYDMVLV | 221 | P19087 | |
| FYDVIDCFSMLHCVI | 301 | O15218 | |
| LLFDISFLMLCHVAQ | 491 | O75448 | |
| CIVLNTLFMALEHYN | 726 | Q14524 | |
| DGMIHLCIYAVSAIT | 366 | Q9C0A6 | |
| MLVLFFALHVCDEVN | 281 | Q16842 | |
| LCVVLYFILMAQSIH | 176 | B9EJG8 | |
| YLYLCVFHMQTSEVI | 181 | O15091 | |
| TFVCTEYILLAIMAF | 111 | Q8NGX8 | |
| RTIYHMFIAGLCVFI | 121 | O75908 | |
| VRIHEYAAISLTACM | 221 | Q8N961 | |
| FATAEEIAMLCVYLA | 211 | Q9BUT1 | |
| LVFILCLYVHMFLLA | 186 | Q01718 | |
| TICDLIMILAFYLVH | 81 | Q96FZ5 | |
| LSFLILYFSHCMIKV | 231 | Q9NYW7 | |
| MHYCVLSAFLILHLV | 1 | P61812 | |
| SIIMLCICANLYFHD | 101 | Q9BU79 | |
| MDVYCFLFTDLLLVT | 601 | O94827 | |
| LLLFLYCHEMSLAFQ | 911 | O15164 | |
| HYMFEAICLSIRITC | 616 | P55060 | |
| VLLHMLLSVGCLAYF | 266 | Q9Y548 | |
| AVVMALLSLHCLAAF | 361 | Q8IUR5 | |
| CRRLTVEFMHYIIAA | 161 | O00541 | |
| MRCLFEAYEHVLSLL | 436 | Q9Y5W7 | |
| QAFTILCDILMIFSH | 786 | Q8N3U4 | |
| VLMLAALLLHCYADS | 6 | O75556 | |
| IAIMAAARHQCSYLI | 111 | P58005 | |
| CIHFFLALYLANDME | 101 | Q495Y7 | |
| LIDYHLAAFITVMLA | 116 | Q9NV64 | |
| YLALATETVDMFHIL | 1086 | O95155 | |
| VIAFGYSMFLCVHVK | 396 | Q86WB7 | |
| ATLVILLAYFVAMHL | 351 | Q6N022 | |
| LAVYRMFGEVHACEL | 881 | Q9H254 | |
| GCIQIVYVHKFFMSL | 1701 | Q709C8 | |
| MLDIECFTYLHRALE | 306 | Q9Y265 | |
| FEALVIYMESLALAH | 1101 | P78527 | |
| CTYFLDHLLVLKMIF | 301 | Q6ZR37 | |
| GHLIMDQSYVCALIA | 416 | Q92508 | |
| HSELLCYFIIILNHM | 1686 | Q92508 | |
| CYFIIILNHMVTASA | 1691 | Q92508 | |
| LYEGMHLLITAAVCV | 956 | Q5H8A4 | |
| VMLLLCYHTFLTFVL | 276 | Q5SRH9 | |
| CIDFMVFTVRLLHIF | 896 | Q8TD43 | |
| LFVYTQVFCHALHIM | 976 | P57678 | |
| AIYFLMIHVLLILCF | 3241 | Q14789 | |
| SVLCFMRHDILEYFS | 56 | A6NI61 | |
| SFYHCALAMSFVLLL | 181 | A6NI61 | |
| VIRAYLECALHTDMA | 156 | Q8N9F0 | |
| FCLLVVVVVLMSRYH | 361 | Q96NY8 |